Andrew Zolopa

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population

David R. Bangsberg, Frederick Hecht, Edwin D. Charlebois et al. · AIDS · 2000 · 1K citations

Public Health, Infectious Diseases, Hiv Control +16

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS

David R. Bangsberg, Sharon Perry, Edwin D. Charlebois et al. · AIDS · 2001 · 968 citations

Public Health, Health Sciences, Disease Surveillance +15

Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial

Andrew Zolopa, Janet Andersen, Lauren Komarow et al. · PLoS ONE · 2009 · 567 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

Paul E. Sax, Edwin DeJesus, Anthony Mills et al. · The Lancet · 2012 · 444 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis Plan

Victor DeGruttola, Lynn P. Dix, Richard T. D’Aquila et al. · Antiviral Therapy · 2000 · 330 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +13